Authors: GRIGORAKI V TSAKRI A GEORGAKOPOULOU SC TSOUFAKIS G ROUMELIOTIS H MATSIS K KALMANTIS T ZIROGIANNIS P ANAGNOSTOPOULOS NI

Citation: V. Grigoraki et al., THE PROGNOSIS OF RENAL-FAILURE IN THE SURVIVAL OF MYELOMA PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 355-355

Authors: GOURGOULIANIS KI LAZARIDES M KARANIKAS J MELISSINOS C ZIROGIANNIS P

Citation: Ki. Gourgoulianis et al., EXAMINING WHICH MEDICAL SPECIALTIES ARE THE MOST ACTIVE IN PRODUCING RESEARCH, Academic medicine, 71(5), 1996, pp. 511-512

Authors: IATROU C MOUSTAKAS G ANTONOPOULOU S DEMOPOULOS CA ZIROGIANNIS P

Citation: C. Iatrou et al., STUDY OF PLATELET-ACTIVATING-FACTOR (PAF) LEVELS AND PAF ACETYLHYDROLASE (AH) ACTIVITIES IN PATIENTS WITH PRIMARY GLOMERULONEPHRITIS (PGN), Journal of lipid mediators and cell signalling, 10(1-2), 1994, pp. 117-118

Authors: ANTONOPOULOU S DEMOPOULOS CA IATROU C MOUSTAKAS G ZIROGIANNIS P

Citation: S. Antonopoulou et al., PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE (PAF-AH) IN HUMAN KIDNEY, International Journal of Biochemistry, 26(9), 1994, pp. 1157-1162

Authors: LATROU C TOPAKAS G SKOUMI D AFENTAKIS N KARCHILAKI E MOUSTAKAS G GERMENIS A STAVROPOULOU A ZIROGIANNIS P

Citation: C. Latrou et al., STUDY OF CELL-MEDIATED-IMMUNITY IN HEMODIALYZED PATIENTS (HDP) AFTER ADMINISTRATION OF BETA-GLYCOSYLATED ERYTHROPOIETIN (BETA-EPO), Kidney international, 44(4), 1993, pp. 912-912

Authors: IATROU C KEFALAS A AFENTAKIS N APTHENTOPOULOS I ANTONOPOULOU S DEMOPOULOS KA STATHOPOULOU R ZIROGIANNIS P

Citation: C. Iatrou et al., THE INFLUENCE OF BETA-GLYCOSYLATED ERYTHROPOIETIN (BETA-EPO) ON PLATELET-AGGREGATION IN HEMODIALYZED PATIENTS (HDP), Kidney international, 44(4), 1993, pp. 912-912